The store will not work correctly when cookies are disabled.
5-chloro-2-(2,5-dimethylphenyl)-2,3-dihydroquinazolin-4(1H)-one
ID: ALA5185774
PubChem CID: 164880782
Max Phase: Preclinical
Molecular Formula: C16H15ClN2O
Molecular Weight: 286.76
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C)c(C2NC(=O)c3c(Cl)cccc3N2)c1
Standard InChI: InChI=1S/C16H15ClN2O/c1-9-6-7-10(2)11(8-9)15-18-13-5-3-4-12(17)14(13)16(20)19-15/h3-8,15,18H,1-2H3,(H,19,20)
Standard InChI Key: ACSIKXIGGISTLO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.5001 0.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7833 -0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -0.2068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 1.0316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 1.4445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 1.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5001 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 2.2702 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0723 -0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0723 -1.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7894 -1.4445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -1.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -0.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 0.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 2.2695 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 1.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7894 -2.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 7 1 0
3 8 2 0
8 9 1 0
9 10 2 0
10 1 1 0
7 11 2 0
5 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
9 18 1 0
17 19 1 0
14 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.76 | Molecular Weight (Monoisotopic): 286.0873 | AlogP: 3.81 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.13 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.50 | CX Basic pKa: ┄ | CX LogP: 4.68 | CX LogD: 4.68 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.84 | Np Likeness Score: -0.90 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |